CG

Caroline Gaynor

Director at Amber Therapeutics

Ireland

Overview 

Caroline Gaynor is a Partner at Lightstone Ventures in Ireland, with a background in Market Access and Regulatory Affairs in the Pharmaceutical Industry. She has held directorial roles at various companies including Amber Therapeutics, Volta Medical, and Carrick Therapeutics, and has invested in companies like Amber Therapeutics and Catamaran Bio at Series A stages. Caroline Gaynor's career highlights include her roles as Director at multiple pharmaceutical and medical device companies, as well as her involvement in investing in early-stage companies like Amber Therapeutics and ProVerum Medical.

Work Experience 

  • Director

    2024 - Current

  • Director

    2024

  • Director

    2023

  • Partner

    2023

  • Principal

    2020 - 2023

  • Vice President

    2016 - 2020

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics.

  • Director

    2022

  • Director

    2021

  • Director

    2020

Catamaran Bio is a biotechnology company that specializes in allogeneic immune cell therapies.

Raised $42,000,000.00 from Astellas Venture Management, Lightstone Ventures, SV Health Investors, Takeda Ventures and Sofinnova Partners.

  • Director

    2014 - 2020

Articles About Caroline

Relevant Websites